NCT02686879

Brief Summary

Hyperopia, also known as farsightedness, is a common type of refractive error where distant objects may be seen more clearly than objects that are near. Hyperopia is a known risk factor for amblyopia, (lazy eye), which may occur as a result of a squint (turn), or due to different levels of hyperopia between each eye (anisohyperopia). Hyperopia and anisohyperopia often persist into adulthood resulting in impairment to binocular vision. Current management involves prescribing spectacles or contact lenses to correct the hyperopia in each eye, usually as a lifelong intervention. In recent years there has been a great deal of interest in delaying progression of myopia (short-sightedness) by slowing down the growth of the eye using a particular type of contact lens termed a centre-distance multifocal design. There have been some encouraging results in this area to date. The proposed study here would explore the use of centre-near multifocal design contact lenses to encourage growth of the eye, thereby reducing hyperopia. There are three elements to the programme of research:

  1. 1.The natural progression of axial growth and refractive error will be measured in hyperopic and anisohyperopic subjects aged between 5 and 19. In other words, the natural growth of the eye will be followed without any intervention
  2. 2.As a paired eye control study anisohyperopes aged between 8 and 15 will be fitted with a centre-near multifocal design contact lens in their more hyperopic eye and a single vision contact lens in the fellow eye, if required. The progression of axial growth and refractive error will be measured and compared in each eye
  3. 3.Subjects' aged between 8 and 15 with similar levels of hyperopia in each eye will be fitted with centre-near multifocal design contact lenses in each eye. The progression of axial growth and refractive error will be measured and compared to subjects in the natural progression study

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 22, 2016

Completed
3 months until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2022

Completed
Last Updated

March 3, 2022

Status Verified

February 1, 2022

Enrollment Period

3.8 years

First QC Date

February 12, 2016

Last Update Submit

February 16, 2022

Conditions

Keywords

hyperopesaxial lengthperipheral defocus

Outcome Measures

Primary Outcomes (1)

  • Measurement in axial length change in mm

    Axial length measured at baseline. Intervention introduced six months after baseline measures for a period of two years. Final measures taken six months after removal of intervention. Total time frame of three years.

    Three years

Secondary Outcomes (1)

  • Measurement of refractive change in dioptres

    Three years

Study Arms (4)

Natural progession

NO INTERVENTION

Following the natural progression of axial growth and refractive error.

Anisohyperopes - intervention eye

EXPERIMENTAL

The more hyperopic eye will be fitted with a centre-near multifocal contact lens

Device: Multifocal contact lenses

Hyperopes

EXPERIMENTAL

Both eyes will be fitted with centre-near multifocal contact lenses.

Device: Multifocal contact lenses

Anisohyperopes - fellow eye

EXPERIMENTAL

The less hyperopic eye will be fitted with a single vision contact lens if required.

Device: Single vision contact lenses

Interventions

Anisohyperopes - intervention eyeHyperopes
Anisohyperopes - fellow eye

Eligibility Criteria

Age5 Years - 19 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Aged between 5 and 19 years at the initial examination for the natural progression arm
  • Aged between 8 and 15 years at the initial examination for the intervention arms
  • Parents must have read, understood and signed informed consent form
  • Participants must have read, understood and signed assent form
  • Participants in the intervention groups agree to wear the prescribed contact lenses for a minimum of 10 hours per day, at least 6 days per week for the 2-year duration of the intervention period
  • Be in good general health with no contraindications to contact lens wear
  • Maximum manifest spherical refractive error of +6.00D
  • Maximum manifest cylindrical refractive error of -1.00D
  • Minimum anisometropia of 1.25D in the anisohyperopic group (mean spherical error)
  • Maximum anisometropia of 1.00D in the non-anisohyperopic group (mean spherical error)
  • Minimum mean spherical refractive error of +2.00D in the more hyperopic eye
  • Be competent at handling contact lenses and understand the instructions given to ensure safe wear.

You may not qualify if:

  • Participating within another clinical study (even if it is only an observational study?)
  • Regular use of medication to treat ocular conditions
  • Current use of systemic medication that may impact upon successful contact lens wear or affect focusing ability
  • Known ocular or systemic disease
  • Findings identified during contact lens assessment that would preclude contact lens wear.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Eyesite Eyecare Centres

Coventry, Walsgrave, CV2 4BA, United Kingdom

Location

Aston University

Birmingham, West Midlands, B4 7ET, United Kingdom

Location

Related Publications (1)

  • Beasley IG, Davies LN, Logan NS. Effect of Peripheral Defocus on Axial Eye Growth and Modulation of Refractive Error in Hyperopes: Protocol for a Nonrandomized Clinical Trial. JMIR Res Protoc. 2018 Sep 5;7(9):e173. doi: 10.2196/resprot.9320.

MeSH Terms

Conditions

HyperopiaAmblyopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2016

First Posted

February 22, 2016

Study Start

June 1, 2016

Primary Completion

March 1, 2020

Study Completion

February 1, 2022

Last Updated

March 3, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations